Cargando…
Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential
In mammalian cells, 10 different adenylyl cyclases produce the ubiquitous second messenger, cyclic adenosine monophosphate (cAMP). Amongst these cAMP-generating enzymes, bicarbonate (HCO(3) (−))-regulated soluble adenylyl cyclase (sAC; ADCY10) is uniquely essential in sperm for reproduction. For thi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554468/ https://www.ncbi.nlm.nih.gov/pubmed/36246105 http://dx.doi.org/10.3389/fphys.2022.1013845 |
_version_ | 1784806703328395264 |
---|---|
author | Rossetti, Thomas Ferreira, Jacob Ghanem, Lubna Buck, Hannes Steegborn, Clemens Myers, Robert W. Meinke, Peter T. Levin, Lonny R. Buck, Jochen |
author_facet | Rossetti, Thomas Ferreira, Jacob Ghanem, Lubna Buck, Hannes Steegborn, Clemens Myers, Robert W. Meinke, Peter T. Levin, Lonny R. Buck, Jochen |
author_sort | Rossetti, Thomas |
collection | PubMed |
description | In mammalian cells, 10 different adenylyl cyclases produce the ubiquitous second messenger, cyclic adenosine monophosphate (cAMP). Amongst these cAMP-generating enzymes, bicarbonate (HCO(3) (−))-regulated soluble adenylyl cyclase (sAC; ADCY10) is uniquely essential in sperm for reproduction. For this reason, sAC has been proposed as a potential therapeutic target for non-hormonal contraceptives for men. Here, we describe key sAC-focused in vitro assays to identify and characterize sAC inhibitors for therapeutic use. The affinity and binding kinetics of an inhibitor can greatly influence in vivo efficacy, therefore, we developed improved assays for assessing these efficacy defining features. |
format | Online Article Text |
id | pubmed-9554468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95544682022-10-13 Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential Rossetti, Thomas Ferreira, Jacob Ghanem, Lubna Buck, Hannes Steegborn, Clemens Myers, Robert W. Meinke, Peter T. Levin, Lonny R. Buck, Jochen Front Physiol Physiology In mammalian cells, 10 different adenylyl cyclases produce the ubiquitous second messenger, cyclic adenosine monophosphate (cAMP). Amongst these cAMP-generating enzymes, bicarbonate (HCO(3) (−))-regulated soluble adenylyl cyclase (sAC; ADCY10) is uniquely essential in sperm for reproduction. For this reason, sAC has been proposed as a potential therapeutic target for non-hormonal contraceptives for men. Here, we describe key sAC-focused in vitro assays to identify and characterize sAC inhibitors for therapeutic use. The affinity and binding kinetics of an inhibitor can greatly influence in vivo efficacy, therefore, we developed improved assays for assessing these efficacy defining features. Frontiers Media S.A. 2022-09-28 /pmc/articles/PMC9554468/ /pubmed/36246105 http://dx.doi.org/10.3389/fphys.2022.1013845 Text en Copyright © 2022 Rossetti, Ferreira, Ghanem, Buck, Steegborn, Myers, Meinke, Levin and Buck. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Rossetti, Thomas Ferreira, Jacob Ghanem, Lubna Buck, Hannes Steegborn, Clemens Myers, Robert W. Meinke, Peter T. Levin, Lonny R. Buck, Jochen Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential |
title | Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential |
title_full | Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential |
title_fullStr | Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential |
title_full_unstemmed | Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential |
title_short | Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential |
title_sort | assessing potency and binding kinetics of soluble adenylyl cyclase (sac) inhibitors to maximize therapeutic potential |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554468/ https://www.ncbi.nlm.nih.gov/pubmed/36246105 http://dx.doi.org/10.3389/fphys.2022.1013845 |
work_keys_str_mv | AT rossettithomas assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT ferreirajacob assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT ghanemlubna assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT buckhannes assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT steegbornclemens assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT myersrobertw assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT meinkepetert assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT levinlonnyr assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential AT buckjochen assessingpotencyandbindingkineticsofsolubleadenylylcyclasesacinhibitorstomaximizetherapeuticpotential |